SH 01 - Breast Cancer - Science Highlights

Presentations

• 08:00am - 08:05am ET

  Long-Term Follow-up of a Prospective Multicenter Trial of Endocrine Therapy without Radiotherapy after Breast-Conserving Surgery for Biologically Favorable Stage: Breast Cancers In Younger Postmenopausal Patients

  Speaker: Reshma Jagsi, MD, PhD, FASTRO - Emory University School of Medicine, Atlanta
• 08:05am - 08:10am ET

  Initial Outcome of The TARGIT-B International Randomised Trial of Targeted Intraoperative Radiotherapy Tumour Bed Boost For young Or High-Risk Patients With Breast Cancer

  Speaker: Jayant Vaidya, MD, MB, PhD, FRCS - University College London, London
• 08:10am - 08:15am ET

  Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer: 10-Year Outcomes from a Phase 3 Randomized Trial

  Speaker: Guang-Yi Sun, MD - National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical, Beijing
• 08:15am - 08:20am ET

  Neoadjuvant Radiotherapy in Breast Cancer: A Study on the Optimal Sequencing of Radiation in Breast Cancer (NeoORB)

  Speaker: Rishi Nair, MBBS - All India Institute of Medical Sciences, Jodhpur, Jodhpur
• 08:20am - 08:25am ET

  Phase I/II Study of Concurrent Abemaciclib and Adjuvant Radiotherapy in Patients with HR+, HER2-, High-Risk Breast Cancer

  Speaker: Yuchun Song, MD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
• 08:25am - 08:30am ET

  Discussant

  Speaker: Leah Katz, MD - Leah Katz, Lawrence